API plant

Pharma

AbbVie plots $10B US outlay as pharma tariff threat looms

With the threat of drug tariffs sparking an investment rush in the U.S., AbbVie is laying plans to spend billions in the country over the next decade.

Fraiser Kansteiner Apr 25, 2025 11:52am

Evotec offloads chemical API facility for undisclosed price

Nov 7, 2024 8:04am

Lilly to spend $4.5B for Indiana R&D and manufacturing site

Oct 2, 2024 8:55am

SK pharmteco to build $260M peptide production plant in Korea

Sep 30, 2024 3:46pm

In Singapore, Pfizer cuts ribbon on $743M extension of API plant

Jul 23, 2024 9:43am

API maker Veranova pledges $30M to expand Massachusetts facility

Jul 1, 2024 9:22am